Related Experiment Videos
Epilepsy with impulsive petit mal (juvenile myoclonic epilepsy)
Acta Neurologica Scandinavica
|November 1, 1985
Summary
Juvenile myoclonic epilepsy (JME) presents with jerking seizures after waking, often triggered by sleep deprivation. While manageable with medication like valproate, a complete cure for this epilepsy syndrome remains elusive.
Area of Science:
- Neurology
- Epileptology
Background:
- Juvenile myoclonic epilepsy (JME) is a primary generalized epilepsy syndrome.
- Characterized by jerking seizures (impulsive petit mal) and generalized tonic-clonic seizures (TCS), predominantly post-awakening.
- EEG shows bilateral-synchronous 4-6/s spike-wave complexes, often with multispike-waves.
Purpose of the Study:
- To describe the clinical and electroencephalographic characteristics of JME.
- To outline the typical age of onset, seizure triggers, and inheritance patterns.
- To discuss treatment options and prognosis for JME.
Main Methods:
- Clinical case descriptions and electroencephalographic findings analysis.
- Review of genetic studies on inheritance patterns.
- Evaluation of treatment efficacy with specific antiepileptic drugs.
Main Results:
- JME onset is typically between 12-18 years, accounting for 4-6% of epilepsies.
- Seizures are provoked by sleep deprivation and occur upon awakening (awakening epilepsy).
- Valproate and primidone show good control, but a complete cure is unlikely.
Conclusions:
- JME is a distinct adolescent-onset epilepsy syndrome with specific clinical and EEG features.
- Genetic factors suggest polygenic inheritance with higher prevalence in women.
- Effective management is possible, but long-term prognosis requires ongoing treatment.